StockVS

NASDAQ · Integrated Freight & Logistics · USD

Cryoport, Inc. (CYRX) Stock Analysis

Cryoport, Inc. (CYRX) is a Integrated Freight & Logistics stock listed on NASDAQ and quoted in US Dollar.

CYRX

$15.81

−$0.05 (−0.32%)

Sep 4, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare CYRX with… →

CYRX Key Statistics

As of Sep 4, 2026
Trading
Open
$15.65
Previous Close
$15.86
Day's Range
15.49–16.00
52-Week Range
7.61–17.20
Volume
316.80K
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
1.90
Valuation
Market Cap
$800.76M
P/E Ratio
unprofitable
PEG RatioThe P/E ratio divided by the expected earnings growth rate. It puts a high P/E in the context of how fast profits are growing.
62.13
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
4.29
EPS (ttm)Profit attributable to each share over the last twelve months.
−0.82
Financials (FY)
Revenue (FY)
$176.18M+12.38%
Net Income (FY)
$78.30M
Profit marginThe share of revenue left as profit after all costs and taxes.
−20.05%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
50.65M
1-Year Return
+78.64%
Dividend and dates
Earnings Date
November 3, 2026estimated
Avg Volume
658.72K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

CYRX Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)+64.69%
2025+23.39%
2024−49.77%
2023−10.72%
2022−70.68%
2021+34.85%
2020+166.59%
2019+49.23%
2018+28.41%
2017+165.12%
2016 (partial year)+50.70%

As of September 4, 2026.

CYRX Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025$176.18M$78.30M44.4%
2024$156.77M−$114.76M−73.2%
2023$168.66M−$99.59M−59.0%
2022$237.28M−$37.33M−15.7%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$176.18M$83.05M−$36.81M$78.30M44.4%
2024$156.77M$69.66M−$57.86M−$114.76M−73.2%
2023$168.66M$75.33M−$50.97M−$99.59M−59.0%
2022$237.28M$103.87M−$31.90M−$37.33M−15.7%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

CYRX Valuation vs Integrated Freight & Logistics Median

Median of 33 stocks
MetricCYRXIntegrated Freight & Logistics medianvs median
P/S ratio4.290.548.0x the median
Profit margin−20.05%0.00%20.1 pts below

Medians across 33 Integrated Freight & Logistics stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.

Recent News

All 8 articles ↓

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

Cryoport, Inc. (CYRX) is capitalised at $800.76M on the latest close. It is classified in the Integrated Freight & Logistics industry, within the Industrials sector. Headcount on file is 684.

The most recent close on file for CYRX is $15.81, dated September 4, 2026. That is −$0.05 (−0.32%) against the previous close. Over the past 52 weeks the price has ranged from $7.61 to $17.20. The latest close sits 107.75% above that 52-week low.

Financial Health

In fiscal 2025, Cryoport, Inc. reported revenue of $176.18M. That is +12.38% against the prior fiscal year, when revenue was $156.77M. Net income for the same year was $78.30M. The reported profit margin is −20.05%. That is 20.1 percentage points below the Integrated Freight & Logistics median of 0%. Earnings per share on a trailing basis come to −0.82.

Across the 4 fiscal years on file, revenue moves from $237.28M in 2022 to $176.18M in 2025. Of those 4 years, 1 report positive net income.

Valuation Assessment

No trailing P/E applies: the last reported earnings figure is negative. The PEG ratio, which sets the P/E against expected earnings growth, reads 62.13. Measured against sales, the shares trade at 4.29 times revenue. On price-to-sales that is 8 times the Integrated Freight & Logistics median of 0.54. The medians here are taken across 33 Integrated Freight & Logistics companies that report the metric.

Beta against the wider market is reported at 1.9. Daily returns over the trailing 10 years annualize to a volatility of 72.4%. Over the trailing twelve months the price has returned +78.64%. Measured over 10 years, that is +23.03% a year compounded.

Growth & Income

The record shows no dividend for CYRX.

So far in 2026 the price is +64.69%. Across the complete calendar years on file, 2020 returned +166.59% and 2022 returned −70.68%. Of the 9 complete calendar years on file, 6 finished higher.

Peer Comparison

Cryoport, Inc. (CYRX) operates in the Integrated Freight & Logistics industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Cryoport, Inc. CYRX $800.76M
United Parcel Service, Inc. UPS $87.03B 19.0
FedEx Corporation FDX $76.33B 17.5
J.B. Hunt Transport Services, Inc. JBHT $25.71B 37.9

The Integrated Freight & Logistics industry average P/E ratio is 23.3x. Cryoport, Inc. has no P/E ratio because it is not currently profitable.

Every figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.

Related Integrated Freight & Logistics Stocks

View all Integrated Freight & Logistics stocks →

Popular Industrials Stocks

View all Industrials stocks →

About Cryoport, Inc.

Cryoport, Inc. provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and reproductive medicine markets worldwide. The company's Life Sciences Services segment provides temperature-controlled logistics and biostorage, bioservices and cryopreservation services within the life science industry. Its Life Sciences Products segment manufactures, and sells cryogenic freezers, cryogenic dewars, and related ancillary accessories within the life science industry through direct sales or a distribution network. The company's products include Cryoport Express Shippers; Cryoport Elite; Cryoport Express Cryogenic HV3 Shipping System; Smartpak Condition Monitoring System and Tec4Med, an IoT-based monitoring solutions; and Cryoport accessories. It also provides Cryoport BioStorage/Bioservices, such as Cryoport Systems Bioservices, including controlled temperature storage, kitting, labelling, fulfillment, sample management, drug return, and Qualified Person drug product release. In addition, the company offers IntegriCell services that comprise apheresis/leukapheresis collection, cryoshuttle transportation, cryo-process optimization, and cryopreservation services; Cryoport consulting services; MVE Fusion cryogenic system, a self-sustaining cryogenic freezer; and MVE Vario cryogenic system, a cryogenic freezer system. Further, it provides biological specimen cryopreservation storage and maintenance; archiving, monitoring, tracking, receipt, and delivery of samples; frozen biological specimens transportation; incoming and outgoing biological specimens management; and short-term logistics and engineering consulting services. The company was founded in 1999 and is based in Brentwood, Tennessee.

Visit website →